CGP-43371

CGP-43371, a Rifampicin (HY-B0272) derivative, is an orally active hypolipidemic agent. CGP-43371 has hypolipidemic and anti-atherosclerotic activities[1].

Product Specifications

CAS Number

[123036-23-7]

UNSPSC

12352005

Target

Drug Derivative

Related Pathways

Others

Field of Research

Cardiovascular Disease

Smiles

O=C(C(C)(C)C)OC(C(C(OC(/C(C)=C\C=C\[C@@H]([C@@H]([C@H]1C)O)C)=N2)=C2C(N3CCN(CC(C(C)=CC(C)=C4)=C4C)CC3)=C5O)=C5C6=C7O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@H](C)[C@@H]1O)([H])OC(C)=O)C)OC)C6=O)=C7C

Molecular Formula

C56H73N3O12

Molecular Weight

980.19

References & Citations

[1]Feldman DL, et al. CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation. Atherosclerosis. 2001 Feb 1;154 (2) :317-28.